PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
9 hedge funds and large institutions have $1.94M invested in PAVmed Inc. Series Z Warrant in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
6% less capital invested
Capital invested by funds: $2.06M → $1.94M (-$119K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$354K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$40.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.1M |
| 2 |
LCS
Levin Capital Strategies
New York
|
-$142K |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$30.6K |
| 4 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$1.86K |
| 5 |
Morgan Stanley
New York
|
-$1.11K |
PAVMZ Hedge Fund Activity: Q2 2021 in Review
9 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2021, worth a combined $1.94M — down 5.8% from $2.06M a quarter earlier.
Fund positioning in PAVMZ was balanced in Q2 2021: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Warberg Asset Management, adding an estimated $354K. The largest seller was Raymond James & Associates, exiting entirely with an estimated $1.1M sold.
- 9 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2021, unchanged from Q1 2021.
- Funds reported $1.94M of PAVmed Inc. Series Z Warrant stock for Q2 2021, down 5.8% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q2 2021 and 1 closed out, a net change of 0 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q2 2021 was Warberg Asset Management, an estimated $354K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q2 2021 was Raymond James & Associates, an estimated $1.1M sold.
Based on aggregated 13F filings for Q2 2021.